huperzine a has been researched along with amyloid beta-peptides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, XC; Wang, R; Zhang, HY | 1 |
| Tang, XC; Yan, H; Zhang, HY | 1 |
| Fu, F; He, J; Li, Y; Liu, W; Sun, K; Tian, J; Ye, L; Yu, P; Yu, X | 1 |
3 other study(ies) available for huperzine a and amyloid beta-peptides
| Article | Year |
|---|---|
Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat.
Topics: Alkaloids; Amyloid beta-Peptides; Animals; Apoptosis; bcl-2-Associated X Protein; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Dose-Response Relationship, Drug; Hippocampus; Humans; In Situ Nick-End Labeling; Infusion Pumps; Injections, Intraventricular; Male; Maze Learning; Memory Disorders; Microscopy, Electron; Nerve Degeneration; Neurons; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tumor Suppressor Protein p53 | 2001 |
Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells.
Topics: Alkaloids; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line; Humans; Injections, Intraventricular; Male; Mutation; Peptide Fragments; Protein Kinase C; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2004 |
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; GPI-Linked Proteins; Injections, Intramuscular; Lactic Acid; Male; Memory; Microspheres; Particle Size; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Technology, Pharmaceutical | 2013 |